BSE filing, NSE: BERVINL. Summary written from the filing by ALFA Finder's alert engine.
Bervin Investment & Leasing Ltd: key numbers
- Share price
- ₹47.50
- Market cap
- ₹28.02 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-15.67 Cr
- P/E (TTM)
- 18.5×Sector 19.1×
- Promoter holding
- 73.55%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bervin Investment & Leasing Ltd
All →Bervin Investment & Leasing Board Meeting Date
Bervin Investment & Leasing scheduled its Board meeting for 4 Nov 2026 to approve un-audited standalone results for Q2 and H1 FY27. The trading window is closed from 1 Oct 2026.
Bervin Investment & Leasing Other Announcement
Bervin Investment & Leasing Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
Bervin Investment & Leasing Annual General Meeting
Bervin Investment and Leasing Limited held its 36th Annual General Meeting on September 28, 2026, where members adopted financial statements and re-appointed a director.
Bervin Investment & Leasing Other Announcement
The company informed shareholders holding physical shares about mandatory PAN/KYC updates and a special window for re-lodging transfer deeds as per SEBI circulars.
Bervin Investment & Leasing Annual General Meeting
Bervin Investment and Leasing Limited has filed its Annual Report and Notice for the 36th Annual General Meeting scheduled for September 28, 2026.
Bervin Investment & Leasing Q1 FY27 Results: Net Loss of ₹0.1 Cr, Loss Narrows
Bervin Investment & Leasing Ltd reported a net loss of ₹0.1 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.1 Cr
Other board meeting date announcements
All →Premier Synthetics Board Meeting Date
Premier Synthetics announced its Board of Directors meeting scheduled for 14 November 2026 to consider unaudited Q2 and H1 results. No financial figures or decisions are reported in this advance notice.
HCP Plastene Bulkpack Board Meeting Date
HCP Plastene Bulkpack scheduled a board meeting for 06 November 2026. It will consider unaudited results for the quarter and half year ending 30 September 2026.
Ultracab (India) Board Meeting Date
Ultracab (India) Ltd intimated that its Board meeting is scheduled for 04-Nov-2026 to consider unaudited standalone financial results. No results or financial figures are disclosed in this advance notice.
Texmaco Infrastructure & Holdings Board Meeting Date
Texmaco has scheduled a Board meeting on November 5, 2026, to approve Q2 and H2 FY27 financial results. Trading window stays closed for insiders pending results declaration.
Astonea Labs Board Meeting Date
Astonea Labs intimated that its Board is scheduled on 14 Nov 2026 to consider unaudited half-year results. The trading window remains closed until 48 hours post-announcement.
AstraZeneca Pharma India Board Meeting Date
AstraZeneca Pharma India scheduled its board meeting for 5 Nov 2026 to approve Q2/H1 FY27 results. The trading window remains closed until 7 Nov 2026.